Next Article in Journal
Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders
Previous Article in Journal
Association Study between BDNF Gene Polymorphisms and Autism by Three-Dimensional Gel-Based Microarray
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Purification, Crystallization and Preliminary X-ray Crystallographic Studies of RAIDD Death-Domain (DD)

Department of Biochemistry, School of Biotechnology at Yeungnam University, Gyeong-san, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2009, 10(6), 2501-2509; https://doi.org/10.3390/ijms10062501
Submission received: 7 April 2009 / Revised: 26 May 2009 / Accepted: 1 June 2009 / Published: 3 June 2009
(This article belongs to the Section Biochemistry)

Abstract

:
Caspase-2 activation by formation of PIDDosome is critical for genotoxic stress induced apoptosis. PIDDosome is composed of three proteins, RAIDD, PIDD, and Caspase-2. RAIDD is an adaptor protein containing an N-terminal Caspase-Recruiting-Domain (CARD) and a C-terminal Death-Domain (DD). Its interactions with Caspase-2 and PIDD through CARD and DD respectively and formation of PIDDosome are important for the activation of Caspase-2. RAIDD DD cloned into pET26b vector was expressed in E. coli cells and purified by nickel affinity chromatography and gel filtration. Although it has been known that the most DDs are not soluble in physiological condition, RAIDD DD was soluble and interacts tightly with PIDD DD in physiological condition. The purified RAIDD DD alone has been crystallized. Crystals are trigonal and belong to space group P3121 (or its enantiomorph P3221) with unit-cell parameters a = 56.3, b = 56.3, c = 64.9 Å and γ = 120°. The crystals were obtained at room temperature and diffracted to 2.0 Å resolution.

1. Introduction

Death-Domains (DDs) are protein interaction modules composed of six-helix bundle. DDs, together with DEDs, CARDs, and PYDs, comprise the DD superfamily and has a pivotal role in apoptosis signaling pathway by mediating homotypic interaction [1,2]. Apoptosis signaling pathway is mediated by sequential activation of caspases that is cysteinyl protease. Activation of caspases is mediated by large molecular complexes in the apoptosis signaling pathway [3,4,5,6].
PIDDosome, caspase-2 activating large molecular complex, is composed of three different protein components including PIDD (p53-induced protein with a DD), RAIDD (RIP-associated ICH-1 homologous protein with a death domain), and caspase-2 [5]. Caspase-2 activation by PIDDosome is critical for genotoxic stress induced apoptosis [7]. PIDD contains 910 residues with seven leucine rich repeats (LRRs), two ZU-5 domains and a C-terminal Death Domain (DD) [8]. PIDD is essential for cell death, which it facilitates by activating caspase-2. In addition, PIDD is also critical for cell survival due to its interaction with RIP1, a kinase that has been implicated in the activation of NF-κB [7]. The results of several studies indicate that PIDD may be a molecular switch that controls the balance between life and death upon genotoxic stress [7]. Caspase-2 is the second caspase to be identified and is the most evolutionarily conserved caspase cross the species of animal [9]. RAIDD, an adaptor protein containing both an N-terminal CARD and a C-terminal DD, interacts to Caspase-2 and PIDD through CARD-CARD and DD-DD respectively [10,11]. Despite the fundamental importance of the Death-Domain superfamily in apoptotic and inflammatory signaling pathways, limited crystal structures are available [12].
As the first step toward elucidating molecular structure of PIDDosome and further understanding homotypic interaction of DD in apoptosis signaling pathway, we over-expressed, purified and crystallized RAIDD DD. Although it has been known that most DDs are not soluble under physiological conditions [13,14], RAIDD DD was soluble and interacts tightly with PIDD DD under physiological conditions. Crystals are trigonal and belong to space group P3121 with unit-cell parameters a = 56.3, b = 56.3, c = 64.9 Å and γ= 120°. The crystals were obtained at room temperature and diffracted to 2.0 Å resolution. Details of the structure of RAIDD DD should enable us to understand the mechanism of the PIDDosome formation via DD:DD interaction.

2. Results and Discussion

2.1. Over-expression and purification of RAIDD DD

As described below in the Experimental section, a DNA fragment encoding the RAIDD DD (94–199) was cloned by the polymerase chain reaction (PCR) using a plasmid DNA containing the full-length RAIDD gene as the template in order to elucidate the molecular structure of RAIDD DD by the X-ray protein crystallography. Ligation of the PCR product to the expression vector pET-26b produces plasmid pET26RAIDD-DD. This vector construction adds an eight-residue tag including C-terminal hexahistidine which has been used as efficient tag for affinity chromatography. The resulting plasmid was transformed into BL21 (DE3) E. coli competent cells and expressed by treating the bacteria with 0.5 mM isopropyl-D-thiogalactopyranoside (IPTG). After Ni-NTA affinity chromatography followed by gel-filtration chromatography, we could obtain pure RAIDD DD protein (Figure 1). The main peak that contains RAIDD DD eluted around 10 kDa position. It indicates RAIDD DD is existed as a monomer in solution.
RAIDD DD was concentrated to 4–6 mg mL−1 using an Millipore concentration kit (Millipore) for crystallization trials. The selenomethionine-substituted RAIDD DD was expressed in the methionine auxotrophic strain B834 (Novagen) grown in minimal medium supplemented with seleno-l-methionine (Sigma) and other nutrients. It was purified and crystallized using the same procedure as used for the native protein.

2.2. Crystallization of RAIDD DD

Crystallization conditions were initially screened at 297K by the hanging-drop vapor-diffusion method using screening kits from Hampton Research (Crystal screening I and II, Natrix, MembFac, SaltRX) and from deCODE Biostructures Group (Wizard I and II). Crystals were grown on a siliconized cover slip by equilibrating a mixture containing 1 μL of protein solution (4–6 mg·mL−1 protein in 20 mM Tris-HCl at pH 8.0, 150 mM NaCl) and 1 μL of a reservoir solution (2 M Na/K phosphate at pH 7.0) against 0.5 ml of reservoir solution. Crystals appeared in three days and grew to a maximum dimension of 0.2 × 0.2 × 0.2 mm (Figure 2). The selenomethionine-substituted RAIDD DD crystals were also grown under the similar condition (2.1 M Na/K phosphate at pH 7.0).

2.3. Preliminary X-ray diffraction studies

For diffraction experiments, crystals were transiently soaked in a solution corresponding to the reservoir solution but supplemented with 20% (v/v) glycerol. The crystals were cryocooled at 110K. A single-wavelength anomalous diffraction (SAD) data set was collected at the selenium peak wavelength (E=12664ev, λ=0.979Å) at the X4A beamline of National Synchrotron Light Source (NSLS). Selenium labeled methionine will be found and the structure will be phased using the program SOLVE/RESOLVE [15]. Data processing and scaling was carried out in the HKL2000 package [16]. A native data set was collected and used for model refinement using CNS [17]. The data-collection statistics are summarized in Table 1. The structure was determined and deposited at protein data bank (PDBID: 2O71) [19].

2.4. Functional test of RAIDD DD

DDs mediate protein-protein interaction. RAIDD DD is protein interaction module that is involved in the interaction to PIDD DD to form a PIDDosome. This homotypic interaction is critical for caspase-2 activation and genotoxic stress induced apoptosis. To test the function of purified RAIDD DD, we purified PIDD DD and analyzed binding ability of RAIDD DD to PIDD DD. Gel-filtration profile and SDS-PAGE clearly showed that RAIDD forms a tight complex with PIDD DD (Figure 3A, 3B). The absolute molecular mass of 103 kDa (Figure 3C), determined by analytical equilibrium ultracentrifugation, indicates that the stoichiometry of the RAIDD DD: PIDD DD complex is 4:4 or 5:5.

3. Experimental Section

3.1. Expression and purification

The construct for expression of human RAIDD DD (94–199) was made as follows. The cDNA of full length RAIDD DD was used as a template for the polymerase chain reaction (PCR) and the plasmid vector pET26b (Novagen, USA) was used to add a hexahistidine tag at the carboxy-terminus of RAIDD DD for affinity purification. PCR products were digested with NdeI and XhoI (New England Biolabs, USA) restriction enzymes and ligated into pET26b. This vector construction adds an eight-residue tag including C-terminal hexahistidine (LEHHHHHH).
The resulting plasmid was transformed into BL21 (DE3) E. coli competent cells. The expression was induced by treating the bacteria with 0.5 mM isopropyl β-d-thiogalactopyranoside (IPTG) for overnight at 293 K. The bacteria were then collected, resuspended and lysed by sonication in 50 mL lysis buffer (20 mM Tris-HCl at pH 7.9, 500 mM NaCl, 5 mM imidazole). The bacterial lysate was then centrifuged at 14,000 g for 1 hr at 277 K. The supernatant fraction was applied to gravity-flow column (Bio-Rad, USA) packed with Ni-NTA affinity resin (Qiagen, USA). The unbound bacterial proteins were removed from the column using washing buffer (20 mM Tris-HCl at pH 7.9, 500 mM NaCl, 60 mM imidazole and 10% glycerol). The C-terminal His6-tagged RAIDD DD was eluted from the column using an elution buffer (20 mM Tris-HCl at pH 8.0, 500 mM NaCl, 250 mM imidazole). The protein purity was further improved by using a Superdex 200 gel filtration column 10/30 (Pharmacia) which was pre-equilibrated with a solution of 20 mM Tris-HCl at pH 8.0 and 150 mM KCl.
RAIDD DD was concentrated to 4–6 mg mL−1 using a Millipore concentration kit (Millipore, USA) for crystallization trials. The selenomethionine-substituted RAIDD DD was expressed in the methionine auxotrophic strain B834 (Novagen, USA) grown in minimal medium supplemented with seleno-l-methionine (Sigma, USA) and other nutrients. It was purified and crystallized using the same procedure as used for the native protein.

3.2. Crystallization

Crystallization conditions were initially screened at 297 K by the hanging-drop vapor-diffusion method using screening kits from Hampton Research (Crystal screening I and II, Natrix, MembFac, SaltRX) and from deCODE Biostructures Group (Wizard I and II). Crystals were grown on a siliconized cover slip by equilibrating a mixture containing 1 μL of protein solution (4–6 mg mL−1 protein in 20 mM Tris-HCl at pH 8.0, 150 mM NaCl) and 1 μL of a reservoir solution (2M Na/K phosphate at pH 7.0) against 0.5 mL of reservoir solution. Crystals appeared in three days and grew to a maximum dimension of 0.2 × 0.2 × 0.2 mm (Figure 1). The selenomethionine-substituted RAIDD DD crystals were also grown under the similar condition (2.1 M Na/K phosphate at pH 7.0).

3.3. Data collection and analysis

For diffraction experiments, crystals were transiently soaked in a solution corresponding to the reservoir solution but supplemented with 20% (v/v) glycerol. The crystals were cryocooled at 110 K using a nitrogen stream (Cryocool, Cryo Industries, New Hampshire, USA). A single-wavelength anomalous diffraction (SAD) data set was collected at the selenium peak wavelength (E=12664ev, λ=0.979Å) at the X4A beamline of National Synchrotron Light Source (NSLS). Data processing and scaling was carried out in the HKL2000 package [16]. A native data set was collected and used for model refinement. The data-collection statistics are summarized in Table 1.

3.4. Gel filtration chromatography

Purification method for PIDD DD is described at Park et al. [18]. Separately purified and quantified RAIDD DD, PIDD DD were incubated for 1hr at room temperature. Following pre-incubation, the mixture was concentrated to 15 ~ 20 mg mL−1 using a concentration kit (Millipore, USA). The concentrated protein mixture was then applied to a Superdex 200 gel-filtration column 10/30 (GE healthcare, USA), which was pre-equilibrated with a solution of 20 mM Tris-HCl at pH 8.0 and 50 mM NaCl. Formation of the complex was then detected by evaluating the positions of the eluted peak followed by SDS-PAGE.

3.5. Ultracentrifugation

Analytical ultracentrifugation experiments were performed using a Beckman XL-1 analytical ultracentrifuge at 298 K. Absorbance was measured at the maximum wavelength as a function of radius at 25,000 rev./min.

4. Conclusions

In the current study, the RAIDD DD (94–199) of human RAIDD was over-expressed and purified. The recombinant RAIDD DD was fully functional by tight binding to PIDD DD which is well known binding partner. The purified RAIDD DD alone has been crystallized. Crystals are trigonal and belong to space group P3121 with unit-cell parameters a = 56.32, b = 56.32, c = 64.95 Å and γ = 120°. The crystals were obtained at room temperature and diffracted to 2.0 Å resolution.

Acknowledgments

We thank Randy Abramowitz and John Schwanof for use of the X4A beamline at NSLS. This study was supported by a Yeungnam University research grant in 2008.

References and Notes

  1. Reed, JC; Doctor, KS; Godzik, A. The domains of apoptosis: A genomics perspective. Sci STKE 2004. [Google Scholar]
  2. Park, HH; Lo, Y; Lin, S; Wang, L; Yang, JK; Wu, H. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol 2007, 25, 561–586. [Google Scholar]
  3. Wajant, H. The Fas signaling pathway: More than a paradigm. Science 2002, 296, 1635–1636. [Google Scholar]
  4. Zou, H; Henzel, WJ; Liu, X; Lutschg, A; Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997, 90, 405–413. [Google Scholar]
  5. Tinel, A; Tschopp, J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004, 304, 843–846. [Google Scholar]
  6. Salvesen, GS. Caspases and apoptosis. Essays Biochem 2002, 38, 9–19. [Google Scholar]
  7. Janssens, S; Tinel, A; Lippens, S; Tschopp, J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell 2005, 123, 1079–1092. [Google Scholar]
  8. Lin, Y; Ma, W; Benchimol, S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet 2000, 26, 122–127. [Google Scholar]
  9. Lassus, P; Opitz-Araya, X; Lazebnik, Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002, 297, 1352–1354. [Google Scholar]
  10. Duan, H; Dixit, VM. RAIDD is a new ‘death’ adaptor molecule. Nature 1997, 385, 86–89. [Google Scholar]
  11. Read, SH; Baliga, BC; Ekert, PG; Vaux, DL; Kumar, SJ. A novel Apaf-1-independent putative caspase-2 activation complex. Cell Biol 2002, 159, 739–745. [Google Scholar]
  12. Xiao, T; Towb, P; Wasserman, SA; Sprang, SR. Three-dimensional structure of a complex between the death domains of pelle and tube. Cell 1999, 99, 545–555. [Google Scholar]
  13. Huang, H; Eberstadt, M; Olejniczak, ET; Meadows, RP; Fesik, S. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 1996, 384, 638–641. [Google Scholar]
  14. Jeong, EJ; Bang, S; Lee, TH; Park, YI; Sim, WS; Kim, KS. The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD. J. Biol. Chem 1999, 274, 16337–16342. [Google Scholar]
  15. Terwilliger, TC; Berendzen, J. Bayesian correlated MAD phasing. Acta Cryst 1997, D53, 571–579. [Google Scholar]
  16. Otwinoski, Z; Minor, W. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol 1997, 276, 307–326. [Google Scholar]
  17. Brünger, AT; Adams, PD; Clore, GM; DeLano, WL; Gros, P; Grosse-Kunsleve, RW; Jiang, JS; Kuszewski, J; Nilges, M; Pannu, NS; Read, RJ; Rice, LM; Simonson, T; Warren, GL. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Cryst 1998, D54, 905–921. [Google Scholar]
  18. Park, HH; Emmanuelle, L; Stefan, R; Solange, C; Thomas, W; Jurg, T; Wu, H. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 2007, 128, 533–546. [Google Scholar]
  19. Park, HH; Wu, H. Crystal structure of RAIDD death domain implicates potential mechanism of PIDDosome assembly. J. Mol. Biol 2006, 357, 358–364. [Google Scholar]
Figure 1. Purification of the RAIDD DD. The profile showing the elution of the RAIDD DD on Gel-filtration chromatography. SDS-PAGE (15% gel) of the purified RAIDD DD.
Figure 1. Purification of the RAIDD DD. The profile showing the elution of the RAIDD DD on Gel-filtration chromatography. SDS-PAGE (15% gel) of the purified RAIDD DD.
Ijms 10 02501f1
Figure 2. Crystal of RAIDD DD. A native RAIDD DD crystal grown in three days in the condition of 2 M Na/K phosphate at pH 7.0. Its approximate dimentions are 0.2 X 0.2 X 0.2 mm.
Figure 2. Crystal of RAIDD DD. A native RAIDD DD crystal grown in three days in the condition of 2 M Na/K phosphate at pH 7.0. Its approximate dimentions are 0.2 X 0.2 X 0.2 mm.
Ijms 10 02501f2
Figure 3. Functional test of RAIDD DD. A. Profile of Gel-filtration chromatography. Elution volume around 12 mL indicates molecular weight of 120 kDa; B. 15 % SDS-PAGE showed that the peak from profile of gel-filtration chromatography is a complex. Fraction #12 and #14 showed that uncomplexed left over proteins; C. The equilibrium radial absorbance profiles at 25,000 rev./min by analytical ultracentrifugation analysis for RAIDD DD: PIDD DD complex.
Figure 3. Functional test of RAIDD DD. A. Profile of Gel-filtration chromatography. Elution volume around 12 mL indicates molecular weight of 120 kDa; B. 15 % SDS-PAGE showed that the peak from profile of gel-filtration chromatography is a complex. Fraction #12 and #14 showed that uncomplexed left over proteins; C. The equilibrium radial absorbance profiles at 25,000 rev./min by analytical ultracentrifugation analysis for RAIDD DD: PIDD DD complex.
Ijms 10 02501f3
Table 1. Crystallographic statistics.
Table 1. Crystallographic statistics.
Data collectionSe-MetNative
Space groupP3121P3121
Cell dimensions
a, b, c56.3Å, 56.3Å, 64.9Å56.1Å, 56.1Å, 64.9Å
Resolution50–2.0Å50–2.0Å
Rsym6.2% (27.4%)5.5% (17.9%)
I/σ(I)17.2 (2.8)14.5 (2.3)
Completeness100.0% (100.0%)99.7% (99.8%)
Redundancy11.0 (10.6)8.9 (8.9)
Table 1. Crystallographic statistics.
Refinement
Resolution50–2.0Å
No. reflections used (completeness)8063 (96.9%)
Rwork/Rfree23.1%/24.1%
No. atoms
Protein704
Water and other small molecule55
Average B-factors
Protein32.0 Å2
Water and other small molecule40.4 Å2
R.m.s deviations
Bond lengths0.005Å
Bond angles1.0°
Ramachandran Plot
Most favored regions91.3%
Additional allowed regions8.7%
Highest resolution shell is shown in parenthesis.

Share and Cite

MDPI and ACS Style

Jang, T.-h.; Park, H.H. Purification, Crystallization and Preliminary X-ray Crystallographic Studies of RAIDD Death-Domain (DD). Int. J. Mol. Sci. 2009, 10, 2501-2509. https://doi.org/10.3390/ijms10062501

AMA Style

Jang T-h, Park HH. Purification, Crystallization and Preliminary X-ray Crystallographic Studies of RAIDD Death-Domain (DD). International Journal of Molecular Sciences. 2009; 10(6):2501-2509. https://doi.org/10.3390/ijms10062501

Chicago/Turabian Style

Jang, Tae-ho, and Hyun Ho Park. 2009. "Purification, Crystallization and Preliminary X-ray Crystallographic Studies of RAIDD Death-Domain (DD)" International Journal of Molecular Sciences 10, no. 6: 2501-2509. https://doi.org/10.3390/ijms10062501

Article Metrics

Back to TopTop